Support provider:
Technology Agency of the Czech republic KAPPA Programme
Funded:
EEA grants
Norway grants
Investigator:
Main investigator:
University hospital Hradec Kralove, Czech republic - assoc. prof. Ondrej Soukup, Ph.D.
Other investigators:
University of Oslo - Prof. Dr. med. Dr. rer. nat. Jens Pahnke E.F.N.
Institute of Experimental Medicine CAS - Mgr. Martin Horak Ph.D.
Bioinova, s.r.o. - MUDr. Peter Bauer Ph.D.
Abstract:
The aim of the project is the development of compounds for the treatment of Alzheimer´s disease (AD). The project will include an approaches of personalized medicine during the development process in the way that novel compounds will be tested in a disease in a dish (DiD) model derived from AD patients.
Project duration:
January 2021–April 2024
